These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 30174414

  • 1. Preparation and characterization of pH-sensitive nanoparticles of budesonide for the treatment of ulcerative colitis.
    Zhou H, Qian H.
    Drug Des Devel Ther; 2018; 12():2601-2609. PubMed ID: 30174414
    [Abstract] [Full Text] [Related]

  • 2. Dual Functional Eudragit® S100/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside for Improved Treatment of Induced Ulcerative Colitis.
    Gao C, Yu S, Zhang X, Dang Y, Han DD, Liu X, Han J, Hui M.
    Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780
    [Abstract] [Full Text] [Related]

  • 3. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases.
    Ali H, Weigmann B, Neurath MF, Collnot EM, Windbergs M, Lehr CM.
    J Control Release; 2014 Jun 10; 183():167-77. PubMed ID: 24685705
    [Abstract] [Full Text] [Related]

  • 4. Budesonide Loaded PLGA Nanoparticles for Targeting the Inflamed Intestinal Mucosa--Pharmaceutical Characterization and Fluorescence Imaging.
    Ali H, Weigmann B, Collnot EM, Khan SA, Windbergs M, Lehr CM.
    Pharm Res; 2016 May 10; 33(5):1085-92. PubMed ID: 26718953
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F, Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Mahzouni P, Dorkoosh F.
    Drug Deliv; 2011 Feb 10; 18(2):122-30. PubMed ID: 20954795
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis.
    Naeem M, Bae J, Oshi MA, Kim MS, Moon HR, Lee BL, Im E, Jung Y, Yoo JW.
    Int J Nanomedicine; 2018 Feb 10; 13():1225-1240. PubMed ID: 29535519
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions.
    Naeem M, Oshi MA, Kim J, Lee J, Cao J, Nurhasni H, Im E, Jung Y, Yoo JW.
    Nanomedicine; 2018 Apr 10; 14(3):823-834. PubMed ID: 29353017
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimization of budesonide compression-coated tablets for colonic delivery.
    Yehia SA, Elshafeey AH, Sayed I, Shehata AH.
    AAPS PharmSciTech; 2009 Apr 10; 10(1):147-57. PubMed ID: 19199041
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.
    Sahib MN, Darwis Y, Peh KK, Abdulameer SA, Tan YT.
    Int J Nanomedicine; 2011 Apr 10; 6():2351-66. PubMed ID: 22072872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Colon specific delivery of budesonide based on triple coated pellets: in vitro/in vivo evaluation.
    Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P.
    Acta Pharm; 2012 Nov 10; 62(3):341-56. PubMed ID: 23470347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.